These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 29020219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center.
    Johnson JR, Johnston B, Thuras P, Launer B, Sokurenko EV, Miller LG.
    mSphere; 2016; 1(6):. PubMed ID: 27904884
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.
    Can F, Kurt-Azap Ö, İspir P, Nurtop E, Seref C, Loçlar İ, Aktaş ON, Orhan YC, Ergonul O.
    J Glob Antimicrob Resist; 2016 Mar; 4():49-52. PubMed ID: 27436393
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
    Hojabri Z, Mirmohammadkhani M, Kamali F, Ghassemi K, Taghavipour S, Pajand O.
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1859-1866. PubMed ID: 28550370
    [Abstract] [Full Text] [Related]

  • 13. The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.
    Johnson JR, Thuras P, Johnston BD, Weissman SJ, Limaye AP, Riddell K, Scholes D, Tchesnokova V, Sokurenko E.
    Clin Infect Dis; 2016 Jun 15; 62(12):1529-1536. PubMed ID: 27025834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.
    Drawz SM, Porter S, Kuskowski MA, Johnston B, Clabots C, Kline S, Ferrieri P, Johnson JR.
    Antimicrob Agents Chemother; 2015 Sep 15; 59(9):5331-9. PubMed ID: 26100703
    [Abstract] [Full Text] [Related]

  • 16. Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.
    Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, Havers S, Sidjabat HE, Gunning E, De Almeida M, Styles K, Paterson DL, ASID CRN.
    Int J Antimicrob Agents; 2015 Apr 15; 45(4):351-8. PubMed ID: 25707371
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans.
    Mohamed M, Clabots C, Porter SB, Thuras P, Johnson JR.
    Antimicrob Agents Chemother; 2016 Aug 15; 60(8):4638-45. PubMed ID: 27185805
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.